RPSE Res.Phm.Reg S

 

TIDMRPSE 
 
RNS Number : 3659O 
Research Pharmaceutical SRV, Inc 
05 March 2009 
 

5 March 2009 
 
 
ReSearch Pharmaceutical Services Inc. 
 
 
Exercise of Options 
 
 
ReSearch Pharmaceutical Services, Inc. (the "Company"), a leading provider of 
clinical development outsourcing solutions to the biopharmaceutical industry, 
announces today the issue of 544 new shares of common stock of $0.0001 each 
("Shares") relating to the exercise of outstanding employee share options at an 
average exercise price of $0.37 per Share. 
 
 
Application has been made for the admission to trading on AIM of 544 new Shares 
and dealings in the new Shares are expected to commence on March 10, 2009. The 
new Shares rank pari passu with the Company's existing issued Shares. 
 
 
Following this issue, the Company will have outstanding 36,746,835 Shares and 
1,357,179 Warrants (as defined in the Company's Readmission Document dated June 
5, 2007) (1). 
 
(1)    These figures exclude the remaining 186,667 Unit Purchase Options and 
approximately 
        2.9 million employee stock options which also remain 
outstanding. 
 
For further information please contact: 
 
 
+--------------------------------------------------+-----------------------+ 
| ReSearch Pharmaceutical Services, Inc.:          | +1-215-540-0700       | 
+--------------------------------------------------+-----------------------+ 
| Daniel M. Perlman, Chairman & Chief Executive    |                       | 
| Officer                                          |                       | 
+--------------------------------------------------+-----------------------+ 
| Steven Bell, Chief Financial Officer             |                       | 
+--------------------------------------------------+-----------------------+ 
|                                                  |                       | 
+--------------------------------------------------+-----------------------+ 
| Nominated Adviser and UK Broker:                 | +44-20-7012-2000      | 
+--------------------------------------------------+-----------------------+ 
| Arbuthnot Securities Limited                     |                       | 
+--------------------------------------------------+-----------------------+ 
| James Steel/Ed Burbidge                          |                       | 
+--------------------------------------------------+-----------------------+ 
 
 
 
 
 
 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 LISSSUSUISUSEDD 
 

Res.Phm.Reg S (LSE:RPSE)
Historical Stock Chart
From Apr 2024 to May 2024

Res.Phm.Reg S (LSE:RPSE)
Historical Stock Chart
From May 2023 to May 2024